These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 2621320)
1. Role of tumour necrosis factor in the enhanced sensitivity of mice to endotoxin after exposure to lead. Dentener MA; Greve JW; Maessen JG; Buurman WA Immunopharmacol Immunotoxicol; 1989; 11(2-3):321-34. PubMed ID: 2621320 [TBL] [Abstract][Full Text] [Related]
2. Effect of tumor necrosis factor antibody on synovial fluid cytokine activities in equine antebrachiocarpal joints injected with endotoxin. Hawkins DL; Cargile JL; MacKay RJ; Broome TA; Skelley LA Am J Vet Res; 1995 Oct; 56(10):1292-9. PubMed ID: 8928945 [TBL] [Abstract][Full Text] [Related]
3. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha. Doherty GM; Lange JR; Langstein HN; Alexander HR; Buresh CM; Norton JA J Immunol; 1992 Sep; 149(5):1666-70. PubMed ID: 1506688 [TBL] [Abstract][Full Text] [Related]
4. Role of tumor necrosis factor-alpha in down-regulation of hepatic cytochrome P450 and P-glycoprotein by endotoxin. Miyoshi M; Nadai M; Nitta A; Ueyama J; Shimizu A; Takagi K; Nabeshima T; Takagi K; Saito K; Hasegawa T Eur J Pharmacol; 2005 Jan; 507(1-3):229-37. PubMed ID: 15659313 [TBL] [Abstract][Full Text] [Related]
5. Roles of growth factors and of tumor necrosis factor-alpha on liver cell proliferation induced in rats by lead nitrate. Shinozuka H; Kubo Y; Katyal SL; Coni P; Ledda-Columbano GM; Columbano A; Nakamura T Lab Invest; 1994 Jul; 71(1):35-41. PubMed ID: 8041116 [TBL] [Abstract][Full Text] [Related]
6. Effect of treatment with a monoclonal antibody against equine tumor necrosis factor (TNF) on clinical, hematologic, and circulating TNF responses of miniature horses given endotoxin. Cargile JL; MacKay RJ; Dankert JR; Skelley L Am J Vet Res; 1995 Nov; 56(11):1451-9. PubMed ID: 8585655 [TBL] [Abstract][Full Text] [Related]
7. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. Eskandari MK; Bolgos G; Miller C; Nguyen DT; DeForge LE; Remick DG J Immunol; 1992 May; 148(9):2724-30. PubMed ID: 1315357 [TBL] [Abstract][Full Text] [Related]
8. Endotoxin-induced cytokine gene expression in vivo. II. Regulation of tumor necrosis factor and interleukin-1 alpha/beta expression and suppression. Ulich TR; Guo KZ; Irwin B; Remick DG; Davatelis GN Am J Pathol; 1990 Nov; 137(5):1173-85. PubMed ID: 2240164 [TBL] [Abstract][Full Text] [Related]
9. Tissue tumor necrosis factor mRNA expression following cecal ligation and puncture or intraperitoneal injection of endotoxin. Hadjiminas DJ; McMasters KM; Peyton JC; Cheadle WG J Surg Res; 1994 Jun; 56(6):549-55. PubMed ID: 8015310 [TBL] [Abstract][Full Text] [Related]
11. Effect of tumor necrosis factor antibody given to horses during early experimentally induced endotoxemia. Barton MH; Bruce EH; Moore JN; Norton N; Anders B; Morris DD Am J Vet Res; 1998 Jun; 59(6):792-7. PubMed ID: 9622754 [TBL] [Abstract][Full Text] [Related]
12. Granulocytopenia reduces release of soluble TNF receptor p75 in endotoxin-stimulated mice: a possible mechanism of enhanced TNF activity. Steinshamn S; Bemelmans MH; Buurman WA; Waage A Cytokine; 1995 Jan; 7(1):50-6. PubMed ID: 7749066 [TBL] [Abstract][Full Text] [Related]
13. Failure to inhibit endotoxin-induced uveitis with antibodies that neutralize tumor necrosis factor. Rosenbaum JT; Boney RS Reg Immunol; 1993; 5(5):299-303. PubMed ID: 8148240 [TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor (TNF) and endotoxin prime effects of PAF in vivo. Heuer HO; Letts G; Meade CJ J Lipid Mediat; 1990; 2 Suppl():S101-8. PubMed ID: 2133276 [TBL] [Abstract][Full Text] [Related]